Gene: ARHGEF12
Official Full Name: Rho guanine nucleotide exchange factor 12provided by HGNC
Gene Summary: Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli working through G protein-coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein has been observed to form a myeloid/lymphoid fusion partner in acute myeloid leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29365 | ARHGEF12 Knockout cell line (HeLa) | Human | ARHGEF12 | 1:3~1:6 | Negative | Online Inquiry |
KO29366 | ARHGEF12 Knockout cell line (HCT 116) | Human | ARHGEF12 | 1:2~1:4 | Negative | Online Inquiry |
KO29367 | ARHGEF12 Knockout cell line (HEK293) | Human | ARHGEF12 | 1:3~1:6 | Negative | Online Inquiry |
KO29368 | ARHGEF12 Knockout cell line (A549) | Human | ARHGEF12 | 1:3~1:4 | Negative | Online Inquiry |
ARHGEF12 Gene Knockout Cell Lines represent a sophisticated tool for the study of cellular signaling pathways and mechanisms. These genetically modified cell lines are designed to exhibit a functional knockout of the ARHGEF12 gene, which encodes for a guanine nucleotide exchange factor (GEF) implicated in the regulation of Rho GTPases. By creating these knockout models, researchers can effectively dissect the roles of ARHGEF12 in various cellular processes, including cytoskeletal dynamics, cell migration, and proliferation.
The primary function of the ARHGEF12 knockout is to facilitate the investigation of downstream signaling pathways affected by the loss of this gene, allowing for an in-depth understanding of its involvement in cellular behaviors and disease states, particularly in cancer research and developmental biology. The depletion of ARHGEF12 provides a clear framework for examining the compensatory mechanisms that may arise in its absence, thereby revealing potential therapeutic targets or biomarkers.
In the scientific landscape, the importance of ARHGEF12 Gene Knockout Cell Lines is underscored by their applications in both fundamental research and the development of novel therapeutic strategies. Their use allows researchers to explore distinct biological phenotypes and the molecular basis of diseases linked to aberrant cell signaling. Furthermore, these knockout cell lines can be utilized in high-throughput screening applications to identify small molecules that can modulate the Rho GTPase signaling axis.
What sets ARHGEF12 Gene Knockout Cell Lines apart from alternative models is their precise gene modification, which ensures that any observed phenotype is a direct consequence of the ARHGEF12 knockout rather than off-target effects. This specificity enhances the reproducibility and reliability of research findings, making these cell lines an invaluable addition to any cellular biology laboratory. Additionally, our commitment to providing high-quality, validated cell lines ensures that researchers can confidently incorporate our products into their experimental designs.
Investing in ARHGEF12 Gene Knockout Cell Lines empowers researchers and clinicians alike to advance their investigations and enhance understanding of complex biological systems. With our expertise in the development and production of reliable biological products, we are proud to support innovation in the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.